Collplant For Profit

CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs. They develop and commercialize tissue repair products for orthobiologics, using their proprietary plant-based genetic engineering technology to produce rhCollagen. Their rhCollagen BioInk is ideal for 3D bioprinting, and they also offer the Vergenix line of rhCollagen products for soft tissue repair and wound healing. Headquartered in Rehovot, Israel, CollPlant aims to be a leader in regenerative medicine, improving people's lives through their innovative collagen technology.

Funding Status: IPO
Headquarters: Rehovot, HaMerkaz, Israel
Founded Date: 1981
Employee Number: 96
Industry: Regenerative Medicine
Technology: Stem cells
Investor Type: For Profit